Endocrinology, Vol 128, 1603-1610, Copyright © 1991 by Endocrine Society

ARTICLES

Regulation of insulin, epidermal growth factor, and transforming growth factor-alpha levels by growth factor-degrading enzymes

BD Gehm and MR Rosner
Ben May Institute, University of Chicago, Illinois 60637.

The mechanisms by which growth factors are degraded and the role this process plays in the regulation of cell growth are not well understood. Insulin degradation is believed to be mediated by a specific metalloprotease, insulin-degrading enzyme (IDE). We have previously shown that IDE can also degrade transforming growth factor-alpha (TGF alpha), but not epidermal growth factor (EGF), in vitro. This selectivity was surprising, since TGF alpha and EGF are structurally similar and bind to the same receptor with comparable affinities. Using a spectrum of protease inhibitors, we have now analyzed the degradation of TGF alpha, EGF, and insulin by human hepatoma HepG2 cells. The results suggest that bacitracin-sensitive metalloproteases are involved in the degradation of TGF alpha and EGF as well as insulin, and that the degradation of TGF alpha, but not EGF, is mediated in part by IDE. Inhibiting the activity of these metalloproteases decreased growth factor depletion, suggesting that these enzymes play an important role in the control of extracellular growth factor levels. The existence of separate degradative pathways for EGF and TGF alpha may explain how the two factors exert differential effects in some systems, and degradation of TGF alpha by IDE would provide a possible mechanism for interaction between the insulin and TGF alpha/EGF signalling systems.

This article has been cited by other articles:

				D. P. Udrisar, M. I. Wanderley, R. C. C. Porto, C. L. P. Cardoso, M. C. L. Barbosa, M. C. Camberos, and J. C. Cresto Androgen- and Estrogen-Dependent Regulation of Insulin-Degrading Enzyme in Subcellular Fractions of Rat Prostate and Uterus Experimental Biology and Medicine, July 1, 2005; 230(7): 479 - 486. [Abstract] [Full Text] [PDF]

				E.-S. Song, M. A. Juliano, L. Juliano, and L. B. Hersh Substrate Activation of Insulin-degrading Enzyme (Insulysin): A POTENTIAL TARGET FOR DRUG DEVELOPMENT J. Biol. Chem., December 12, 2003; 278(50): 49789 - 49794. [Abstract] [Full Text] [PDF]

				C. E. Murata and D. E. Goldberg Plasmodium falciparum Falcilysin: A METALLOPROTEASE WITH DUAL SPECIFICITY J. Biol. Chem., September 26, 2003; 278(39): 38022 - 38028. [Abstract] [Full Text] [PDF]

				M.C. Camberos, A.A. Pérez, D.P. Udrisar, M.I. Wanderley, and J.C. Cresto ATP Inhibits Insulin-Degrading Enzyme Activity Experimental Biology and Medicine, April 1, 2001; 226(4): 334 - 341. [Abstract] [Full Text]

				K. K. Eggleson, K. L. Duffin, and D. E. Goldberg Identification and Characterization of Falcilysin, a Metallopeptidase Involved in Hemoglobin Catabolism within the Malaria Parasite Plasmodium falciparum J. Biol. Chem., November 5, 1999; 274(45): 32411 - 32417. [Abstract] [Full Text] [PDF]

				W. C. Duckworth, R. G. Bennett, and F. G. Hamel Insulin Degradation: Progress and Potential Endocr. Rev., October 1, 1998; 19(5): 608 - 624. [Abstract] [Full Text]

				F. G. Hamel, R. G. Bennett, and W. C. Duckworth Regulation of Multicatalytic Enzyme Activity by Insulin and the Insulin-Degrading Enzyme Endocrinology, October 1, 1998; 139(10): 4061 - 4066. [Abstract] [Full Text] [PDF]

				V. Chesneau, R. K. Perlman, W. Li, G.-A. Keller, and M. R. Rosner Insulin-Degrading Enzyme Does Not Require Peroxisomal Localization for Insulin Degradation Endocrinology, August 1, 1997; 138(8): 3444 - 3451. [Abstract] [Full Text] [PDF]